Korea's improved version of Nexium obtains final approval from US FDA

An incrementally modified (IMD) drug developed by a Korean drug company that treats gastro-esophageal reflex disease has received a final approval from the U.S. Food and Drug Administration (FDA) for the first time.

Hanmi Pharmaceutical has won approval from the Food and Drug Administration of the United States for sale of Esomezol in the country, the health and welfare ministry said Wednesd...